111 results on '"Nelson, Michelle H."'
Search Results
2. Supplementary Data from The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
3. Data from The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
4. Supplemental Figure S4 from Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling
5. Supplementary Data from IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors
6. Data from IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors
7. Supplemental Figure Legend from Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling
8. Th17 Cells in Cancer
9. The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
10. Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cell therapy
11. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic
12. Abstract 3434: APVO442 is a distinct PSMA x CD3 targeted bispecific candidate designed to optimize T cell fitness and distribution to solid tumors
13. RNA Repair Restores Hemoglobin Expression in IVS2-654 Thalassemic Mice
14. Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions
15. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection
16. Abstract LB173: APVO603: A dual 4-1BB and OX40 bispecific approach utilizing ADAPTIRTMtechnology designed to deliver a conditional T cell/NK response against solid tumors
17. Abstract LB172: APVO442: A bispecific T cell-engaging candidate utilizing the ADAPTIR-FLEXTMplatform technology with unique properties designed for optimal tumor distribution and cytotoxic response against PSMA-expressing solid tumors
18. IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors
19. Identification of human CD4 + T cell populations with distinct antitumor activity
20. RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity
21. Identification of human CD4+ T cell populations with distinct antitumor activity
22. The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
23. Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity
24. RNA-Binding Protein PCBP1/hnRNP E1 is an Intracellular Checkpoint for Shaping Effector Versus Regulatory T Cells in Immunity and Cancer
25. Identification of human CD4+ T cell populations with distinct antitumor activity.
26. Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence
27. PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
28. PI3Kδ inhibition supports memory T cells with enhanced antitumor fitness
29. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
30. β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity
31. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
32. Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
33. Harnessing the Microbiome to Enhance Cancer Immunotherapy
34. A feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
35. Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning
36. Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence.
37. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling
38. The Inducible Costimulator Augments Tc17 Cell Responses to Self and Tumor Tissue
39. Novel immunotherapies for hematologic malignancies
40. Pi3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T cells.
41. Th17 Cells in Cancer: The Ultimate Identity Crisis
42. Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning.
43. Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling
44. Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine
45. Effector function and efficacy of CD8+ T cells activated in the absence of IFN‐γ
46. Novel immunotherapies for hematologic malignancies.
47. Arginine-Rich Peptide Conjugation to Morpholino Oligomers: Effects on Antisense Activity and Specificity
48. Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich Peptides
49. Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions
50. The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.